Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis
- DOI
- 10.1016/j.jns.2024.123264
- Published
- 2024-11
- Container
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jns.2024.123264,
title = {Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis},
author = {Sarah Dewilde and Alison Griffiths and Cynthia Z. Qi and Glenn Phillips and Deborah Gelinas and Edward Brauer and Renato Mantegazza and James F. Howard},
year = {2024},
journal = {Journal of the Neurological Sciences},
doi = {10.1016/j.jns.2024.123264},
url = {https://doi.org/10.1016/j.jns.2024.123264}
}RIS
TY - JOUR TI - Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis AU - Sarah Dewilde AU - Alison Griffiths AU - Cynthia Z. Qi AU - Glenn Phillips AU - Deborah Gelinas AU - Edward Brauer AU - Renato Mantegazza AU - James F. Howard PY - 2024 JO - Journal of the Neurological Sciences DO - 10.1016/j.jns.2024.123264 UR - https://doi.org/10.1016/j.jns.2024.123264 ER -
APA
Dewilde, S., Griffiths, A., Qi, C. Z., Phillips, G., Gelinas, D., Brauer, E., Mantegazza, R., & Howard, J. F. (2024). Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2024.123264
Source records
- crossref · retrieved 2026-09-26T14:10:53.586Z